T1	Participants 377 489	Seventy-two consecutive anti-HBe-positive chronic hepatitis B patients (59 male and 13 female, median age 41 yr)
T2	Participants 571 596	Twenty-seven patients (A)
T3	Participants 1304 1326	12, 8, and 13 patients
T4	Participants 1332 1350	groups A, B, and C
T5	Participants 1410 1464	two patients in group A and only one in groups B and C
T6	Participants 1555 1563	patients
T7	Participants 692 720	(B) received 9 million units
T8	Participants 843 881	24 (C) received 2 alpha-2a IFN courses
